| Real-world outcome of rTMS treatment for depression within the Japanese public health insurance system: Registry data from Kansai TMS network S Imazu, S Ikeda, Y Toi, S Sano, T Kanazawa, K Shinosaki, B Tsukuda, ... Asian Journal of Psychiatry, 104082, 2024 | 1 | 2024 |
| Live two‐way video versus face‐to‐face treatment for depression, anxiety, and obsessive‐compulsive disorder: A 24‐week randomized controlled trial T Kishimoto, S Kinoshita, M Kitazawa, A Hishimoto, T Asami, A Suda, ... Psychiatry and Clinical Neurosciences 78 (4), 220-228, 2024 | 2 | 2024 |
| Beyond lecanemab: Examining Phase III potential in Alzheimer's therapeutics H Osaka, K Nishida, T Kanazawa Psychiatry and Clinical Neurosciences Reports 3 (1), e185, 2024 | | 2024 |
| Psychiatrists’ Perspectives on Advantages, Disadvantages and Challenging for Promotion Related to Telemedicine: Japan’s Clinical Experience During COVID-19 Pandemic S Kinoshita, M Kitazawa, Y Abe, A Suda, T Nakamae, T Kanazawa, ... Journal of Technology in Behavioral Science, 1-10, 2023 | | 2023 |
| Event-related PTSD symptoms as a high-risk factor for suicide: longitudinal observational study T Chiba, K Ide, M Murakami, N Kobayashi, T Oka, F Nakai, R Yorizawa, ... Nature Mental Health 1 (12), 1013-1022, 2023 | 3 | 2023 |
| Emerging trends in antipsychotic and antidepressant drug development: Targeting nonmonoamine receptors and innovative mechanisms H Osaka, T Kanazawa Psychiatry and Clinical Neurosciences Reports 2 (4), e157, 2023 | 2 | 2023 |
| Current practice for clozapine-induced leukopenia in Japanese psychiatric hospitals: A nationwide survey T Niitsu, N Yasui-Furukori, K Inada, T Kanazawa, M Iyo, T Ueno, ... Schizophrenia Research, 2023 | 1 | 2023 |
| Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia Y Aoki, Y Takaesu, K Matsui, T Tokumasu, H Tani, Y Takekita, ... Neuropsychopharmacology Reports 43 (3), 391-402, 2023 | | 2023 |
| Bispectral EEG (BSEEG) algorithm captures high mortality risk among 1,077 patients: its relationship to delirium motor subtype Y Nishizawa, T Yamanashi, T Saito, P Marra, KJ Crutchley, NE Wahba, ... The American journal of geriatric psychiatry 31 (9), 704-715, 2023 | 5 | 2023 |
| Unexpected cause of repeated peritoneal dialysis-related complications: a case study of autism spectrum disorder with normal intelligence quotient in an adolescent Y Fujii, H Matsumura, A Shirasu, H Nakakura, S Yamazaki, T Kanazawa, ... Renal Replacement Therapy 9 (1), 16, 2023 | | 2023 |
| Integrating molecular research into clinical psychiatry: An application to schizophrenia and mood disorders T Kanazawa, S Boku, H Toda, R Ishii Frontiers in Psychiatry 14, 1085663, 2023 | | 2023 |
| Differential genetic correlations across major psychiatric disorders between Eastern and Western countries T Saito, M Ikeda, C Terao, T Ashizawa, M Miyata, S Tanaka, T Kanazawa, ... Psychiatry and clinical neurosciences 77 (2), 118, 2023 | 2 | 2023 |
| Treatment Interventions in Three Adolescent Female Patients with Eating Problems Due to Dysfunctional Family Relationships K Yoichiro, K FUJIMOTO, N ONISHI, Y TAKEI, A SAKAGUCHI, ... Osaka Medical and Pharmaceutical University 69 (1-2), 31-36, 2023 | | 2023 |
| rTMS Therapy Reduces Hypofrontality in Patients With Depression (n= 30) as Measured by fNIRS S Imazu, Y Kawabata, T Kanazawa Brain Stimulation: Basic, Translational, and Clinical Research in …, 2023 | | 2023 |
| Genome-wide DNA methylation analysis of post-operative delirium with brain, blood, saliva, and buccal samples from neurosurgery patients NE Wahba, Y Nishizawa, PS Marra, T Yamanashi, KJ Crutchley, T Nagao, ... Journal of psychiatric research 156, 245-251, 2022 | 5 | 2022 |
| Proportion of subjects with psychotic features in bipolar disorder correlated with treatment response by antipsychotics for acute mania M Ikeda, T Saito, T Kanazawa, T Kishi, N Iwata Psychiatry and clinical neurosciences 76 (11), 596, 2022 | 1 | 2022 |
| rTMS therapy reduces hypofrontality in patients with depression as measured by fNIRS Y Kawabata, S Imazu, K Matsumoto, K Toyoda, M Kawano, Y Kubo, ... Frontiers in Psychiatry 13, 814611, 2022 | 6 | 2022 |
| Neuromodulation for treatment-resistant depression: Including a comparison of modified electroconvulsive therapy and repetitive transcranial magnetic stimulation therapy. SI IMAZU, T KAMASE, Y KUBO, SYA KINOSHITA, T KANAZAWA 精神科治療学 37 (8), 871-876, 2022 | | 2022 |
| Japanese project for telepsychiatry evaluation during COVID-19: Treatment comparison trial (J-PROTECT): Rationale, design, and methodology T Kishimoto, S Kinoshita, S Bun, Y Sato, M Kitazawa, T Kikuchi, M Sado, ... Contemporary Clinical Trials 111, 106596, 2021 | 10 | 2021 |
| Multiple time measurements of multidimensional psychiatric states from immediately before the COVID-19 pandemic to one year later: a longitudinal online survey of the Japanese … T Oka, T Kubo, N Kobayashi, F Nakai, Y Miyake, T Hamamura, M Honjo, ... Translational Psychiatry 11 (1), 573, 2021 | 14 | 2021 |
